Blog Posts

Nagla Abdel Karim

Oct 21, 2024, 08:47

Nagla Abdel Karim: Advances in molecular targets for NSCLC

Nagla Abdel Karim shared the following on X:

“Mariam Alexander presents all about before & after molecular targets in resectable NSCLC. Neoadjuvant Target Therapies awaiting more data.”

cancer DC Lung 24 DCLung24 Mariam Alexander Nagla Abdel Karim neoadjuvant therapy NSCLC OncoDaily Oncology

FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC

Hesham ElGhazaly: Global Inclusion in Clinical Trials at Vision Europe 2025

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

Arnaud Lallouette: Servier and IDEAYA Partner to Bring a Promising Uveal Melanoma Treatment

100 Oncologists, One Community: Reflections from the First ESO College Convention

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Insight

Sep 4, 2025, 20:03

Aruni Ghose: AI-Enhanced Medical Imaging for Cancer Diagnosis

Insight

Sep 4, 2025, 19:35

A Reminder That Education Is Essential to Patient Care - Elekta

Dialogues

Sep 4, 2025, 18:19

MASCC 2025 Presidential Training Fellowship Spotlight: Dr. Colleen Ann Cuthbert

Immune Oncology

Sep 4, 2025, 16:49

LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC

OncoDaily Pulse

Sep 4, 2025, 16:17

Mariam Sargsyan: Meet the Experts of VIRO 2025

OncoDaily Pulse

Sep 4, 2025, 16:08

Elizabeth Wulff-Burchfield: Meet the Experts of VIRO 2025

Voices

Sep 4, 2025, 15:59

Markus Kosch: Finding Strength After Diagnosis - A Conversation with Claudia Poguntke

Voices

Sep 4, 2025, 15:59

Common Sense Oncology India Hub Webinar – Insights on the MATTERHORN Trial

Voices

Sep 4, 2025, 15:56

Servier and IDEAYA Biosciences Partner to Advance Darovasertib for Uveal Melanoma

Voices

Sep 4, 2025, 15:55

Bridging Divides, Building Futures at the 2025 World Cancer Leaders’ Summit - UICC

Insight

Sep 4, 2025, 15:51

Christine Maheu: Systematic Review of Fear of Cancer Recurrence Measures

Voices

Sep 4, 2025, 15:49

Svetlana Nikic: My Journey in Precision Oncology